This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

GO-203-2c

Genus Oncology, LLC

Drug Names(s): GO-203-2c

Description: GO-203-2c is a peptide drug candidate from a series of first-in-class agents synthesized to target MUC1, an oncoprotein that is over-expressed in many diverse human carcinomas including breast, prostate, lung, colon, pancreas, and ovary that have been associated with poor prognosis.


GO-203-2c News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug